nodes	percent_of_prediction	percent_of_DWPC	metapath
Tofisopam—PDE3A—penis—Crohn's disease	0.28	0.373	CbGeAlD
Tofisopam—PDE2A—mouth—Crohn's disease	0.148	0.198	CbGeAlD
Tofisopam—PDE2A—mammalian vulva—Crohn's disease	0.0749	0.0998	CbGeAlD
Tofisopam—PDE10A—digestive system—Crohn's disease	0.0657	0.0875	CbGeAlD
Tofisopam—Verapamil—SLC22A4—Crohn's disease	0.0511	0.571	CrCbGaD
Tofisopam—PDE3A—smooth muscle tissue—Crohn's disease	0.0474	0.0631	CbGeAlD
Tofisopam—Verapamil—SLC22A5—Crohn's disease	0.0384	0.429	CrCbGaD
Tofisopam—PDE10A—lymph node—Crohn's disease	0.0375	0.05	CbGeAlD
Tofisopam—PDE2A—lymph node—Crohn's disease	0.0375	0.05	CbGeAlD
Tofisopam—PDE4A—lymph node—Crohn's disease	0.0258	0.0344	CbGeAlD
Tofisopam—PDE3A—lymph node—Crohn's disease	0.0214	0.0285	CbGeAlD
Tofisopam—CYP3A4—digestive system—Crohn's disease	0.012	0.016	CbGeAlD
Tofisopam—PDE2A—G alpha (s) signalling events—PTGER4—Crohn's disease	0.00592	0.0371	CbGpPWpGaD
Tofisopam—PDE10A—G alpha (s) signalling events—PTGER4—Crohn's disease	0.00448	0.0281	CbGpPWpGaD
Tofisopam—PDE2A—GPCR downstream signaling—MLN—Crohn's disease	0.003	0.0188	CbGpPWpGaD
Tofisopam—PDE2A—Signaling by GPCR—ACKR2—Crohn's disease	0.00288	0.018	CbGpPWpGaD
Tofisopam—PDE2A—Hemostasis—F5—Crohn's disease	0.00273	0.0171	CbGpPWpGaD
Tofisopam—PDE2A—Signaling by GPCR—MLN—Crohn's disease	0.00273	0.0171	CbGpPWpGaD
Tofisopam—PDE4A—G alpha (s) signalling events—PTGER4—Crohn's disease	0.00272	0.017	CbGpPWpGaD
Tofisopam—PDE3A—G alpha (s) signalling events—PTGER4—Crohn's disease	0.00264	0.0166	CbGpPWpGaD
Tofisopam—PDE10A—GPCR downstream signaling—MLN—Crohn's disease	0.00228	0.0143	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—ACKR2—Crohn's disease	0.00218	0.0137	CbGpPWpGaD
Tofisopam—PDE2A—GPCR downstream signaling—CCR9—Crohn's disease	0.00208	0.013	CbGpPWpGaD
Tofisopam—PDE10A—Hemostasis—F5—Crohn's disease	0.00207	0.013	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—MLN—Crohn's disease	0.00207	0.0129	CbGpPWpGaD
Tofisopam—PDE2A—GPCR downstream signaling—GPR65—Crohn's disease	0.00194	0.0121	CbGpPWpGaD
Tofisopam—PDE2A—Signaling by GPCR—CCR9—Crohn's disease	0.00189	0.0118	CbGpPWpGaD
Tofisopam—PDE2A—Signaling by GPCR—GPR65—Crohn's disease	0.00176	0.011	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—ACKR2—Crohn's disease	0.0017	0.0106	CbGpPWpGaD
Tofisopam—PDE2A—Hemostasis—ITGA4—Crohn's disease	0.00168	0.0105	CbGpPWpGaD
Tofisopam—PDE2A—Hemostasis—IL3—Crohn's disease	0.00164	0.0102	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—MLN—Crohn's disease	0.00161	0.0101	CbGpPWpGaD
Tofisopam—PDE2A—Hemostasis—RASGRP1—Crohn's disease	0.00158	0.00991	CbGpPWpGaD
Tofisopam—PDE10A—GPCR downstream signaling—CCR9—Crohn's disease	0.00158	0.00988	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—TAGAP—Crohn's disease	0.00147	0.00923	CbGpPWpGaD
Tofisopam—PDE10A—GPCR downstream signaling—GPR65—Crohn's disease	0.00147	0.00918	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—CCR9—Crohn's disease	0.00143	0.00897	CbGpPWpGaD
Tofisopam—PDE4A—GPCR downstream signaling—MLN—Crohn's disease	0.00138	0.00864	CbGpPWpGaD
Tofisopam—PDE2A—GPCR downstream signaling—CCR6—Crohn's disease	0.00138	0.00864	CbGpPWpGaD
Tofisopam—PDE3A—GPCR downstream signaling—MLN—Crohn's disease	0.00134	0.0084	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—GPR65—Crohn's disease	0.00133	0.00834	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—ACKR2—Crohn's disease	0.00132	0.00827	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—RSPO3—Crohn's disease	0.00129	0.00807	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—ACKR2—Crohn's disease	0.00129	0.00807	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—ACKR2—Crohn's disease	0.00129	0.00805	CbGpPWpGaD
Tofisopam—PDE10A—Hemostasis—ITGA4—Crohn's disease	0.00127	0.00796	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—MLN—Crohn's disease	0.00125	0.00784	CbGpPWpGaD
Tofisopam—PDE2A—Signaling by GPCR—CCR6—Crohn's disease	0.00125	0.00784	CbGpPWpGaD
Tofisopam—PDE10A—Hemostasis—IL3—Crohn's disease	0.00124	0.00777	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—SEL1L—Crohn's disease	0.00122	0.00765	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—MLN—Crohn's disease	0.00122	0.00765	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—F5—Crohn's disease	0.00122	0.00763	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—MLN—Crohn's disease	0.00122	0.00763	CbGpPWpGaD
Tofisopam—PDE2A—GPCR downstream signaling—PTGER4—Crohn's disease	0.00121	0.0076	CbGpPWpGaD
Tofisopam—PDE10A—Hemostasis—RASGRP1—Crohn's disease	0.0012	0.00751	CbGpPWpGaD
Tofisopam—PDE2A—Hemostasis—IL2RA—Crohn's disease	0.00115	0.00718	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—TAGAP—Crohn's disease	0.00112	0.00699	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—CCR9—Crohn's disease	0.00112	0.00699	CbGpPWpGaD
Tofisopam—PDE2A—Signaling by GPCR—PTGER4—Crohn's disease	0.0011	0.0069	CbGpPWpGaD
Tofisopam—PDE10A—GPCR downstream signaling—CCR6—Crohn's disease	0.00105	0.00654	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—GPR65—Crohn's disease	0.00104	0.0065	CbGpPWpGaD
Tofisopam—PDE2A—GPCR downstream signaling—IL3—Crohn's disease	0.00103	0.00648	CbGpPWpGaD
Tofisopam—PDE2A—GPCR downstream signaling—RASGRP1—Crohn's disease	0.001	0.00626	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—RSPO3—Crohn's disease	0.000976	0.00611	CbGpPWpGaD
Tofisopam—PDE4A—GPCR downstream signaling—CCR9—Crohn's disease	0.000956	0.00599	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—CCR6—Crohn's disease	0.000949	0.00594	CbGpPWpGaD
Tofisopam—PDE2A—Signaling by GPCR—IL3—Crohn's disease	0.000939	0.00588	CbGpPWpGaD
Tofisopam—PDE3A—GPCR downstream signaling—CCR9—Crohn's disease	0.00093	0.00582	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—SEL1L—Crohn's disease	0.000925	0.00579	CbGpPWpGaD
Tofisopam—PDE10A—GPCR downstream signaling—PTGER4—Crohn's disease	0.00092	0.00576	CbGpPWpGaD
Tofisopam—PDE2A—Signaling by GPCR—RASGRP1—Crohn's disease	0.000908	0.00569	CbGpPWpGaD
Tofisopam—PDE4A—GPCR downstream signaling—GPR65—Crohn's disease	0.000889	0.00556	CbGpPWpGaD
Tofisopam—PDE10A—Hemostasis—IL2RA—Crohn's disease	0.000869	0.00544	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—CCR9—Crohn's disease	0.000868	0.00544	CbGpPWpGaD
Tofisopam—PDE3A—GPCR downstream signaling—GPR65—Crohn's disease	0.000865	0.00541	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—CCR9—Crohn's disease	0.000846	0.0053	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—CCR9—Crohn's disease	0.000844	0.00529	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—PTGER4—Crohn's disease	0.000836	0.00523	CbGpPWpGaD
Tofisopam—PDE2A—Hemostasis—ALB—Crohn's disease	0.000829	0.00519	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—GPR65—Crohn's disease	0.000807	0.00505	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—GPR65—Crohn's disease	0.000787	0.00493	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—GPR65—Crohn's disease	0.000785	0.00492	CbGpPWpGaD
Tofisopam—PDE10A—GPCR downstream signaling—IL3—Crohn's disease	0.000784	0.00491	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—ACKR2—Crohn's disease	0.00078	0.00489	CbGpPWpGaD
Tofisopam—PDE2A—Hemostasis—JAK2—Crohn's disease	0.000771	0.00482	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—ACKR2—Crohn's disease	0.000759	0.00475	CbGpPWpGaD
Tofisopam—PDE10A—GPCR downstream signaling—RASGRP1—Crohn's disease	0.000758	0.00475	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—ITGA4—Crohn's disease	0.00075	0.00469	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—MLN—Crohn's disease	0.00074	0.00463	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—CCR6—Crohn's disease	0.00074	0.00463	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—IL3—Crohn's disease	0.000731	0.00458	CbGpPWpGaD
Tofisopam—PDE2A—GPCR downstream signaling—IL2RA—Crohn's disease	0.000724	0.00454	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—MLN—Crohn's disease	0.00072	0.00451	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—IL3—Crohn's disease	0.000712	0.00446	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—RASGRP1—Crohn's disease	0.000707	0.00443	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—RASGRP1—Crohn's disease	0.000688	0.00431	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—TAGAP—Crohn's disease	0.000677	0.00424	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—RBX1—Crohn's disease	0.000669	0.00419	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—TAGAP—Crohn's disease	0.000658	0.00412	CbGpPWpGaD
Tofisopam—PDE2A—Signaling by GPCR—IL2RA—Crohn's disease	0.000658	0.00412	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—PTGER4—Crohn's disease	0.000651	0.00408	CbGpPWpGaD
Tofisopam—PDE4A—GPCR downstream signaling—CCR6—Crohn's disease	0.000633	0.00396	CbGpPWpGaD
Tofisopam—PDE10A—Hemostasis—ALB—Crohn's disease	0.000628	0.00393	CbGpPWpGaD
Tofisopam—PDE3A—GPCR downstream signaling—CCR6—Crohn's disease	0.000616	0.00386	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—RSPO3—Crohn's disease	0.000591	0.0037	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—UBE2D1—Crohn's disease	0.000587	0.00367	CbGpPWpGaD
Tofisopam—PDE10A—Hemostasis—JAK2—Crohn's disease	0.000584	0.00366	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—RSPO3—Crohn's disease	0.000575	0.0036	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—CCR6—Crohn's disease	0.000575	0.0036	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—RIPK2—Crohn's disease	0.000569	0.00356	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—SEL1L—Crohn's disease	0.000561	0.00351	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—CCR6—Crohn's disease	0.000561	0.00351	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—CCR6—Crohn's disease	0.000559	0.0035	CbGpPWpGaD
Tofisopam—PDE4A—GPCR downstream signaling—PTGER4—Crohn's disease	0.000558	0.00349	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—IL3—Crohn's disease	0.000555	0.00347	CbGpPWpGaD
Tofisopam—PDE10A—GPCR downstream signaling—IL2RA—Crohn's disease	0.000549	0.00344	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—SEL1L—Crohn's disease	0.000545	0.00342	CbGpPWpGaD
Tofisopam—PDE3A—GPCR downstream signaling—PTGER4—Crohn's disease	0.000542	0.0034	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—RASGRP1—Crohn's disease	0.000537	0.00336	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—CCR9—Crohn's disease	0.000513	0.00321	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—IL2RA—Crohn's disease	0.000512	0.00321	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—RBX1—Crohn's disease	0.000507	0.00317	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—PTGER4—Crohn's disease	0.000506	0.00317	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—CCR9—Crohn's disease	0.000499	0.00312	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—IL2RA—Crohn's disease	0.000499	0.00312	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—PTGER4—Crohn's disease	0.000494	0.00309	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—PTGER4—Crohn's disease	0.000492	0.00308	CbGpPWpGaD
Tofisopam—PDE2A—GPCR downstream signaling—JAK2—Crohn's disease	0.000487	0.00305	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—SOCS1—Crohn's disease	0.000486	0.00304	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—GPR65—Crohn's disease	0.000477	0.00299	CbGpPWpGaD
Tofisopam—PDE4A—GPCR downstream signaling—IL3—Crohn's disease	0.000475	0.00297	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—GPR65—Crohn's disease	0.000464	0.0029	CbGpPWpGaD
Tofisopam—PDE2A—Signaling by GPCR—TYK2—Crohn's disease	0.000464	0.0029	CbGpPWpGaD
Tofisopam—PDE3A—GPCR downstream signaling—IL3—Crohn's disease	0.000462	0.00289	CbGpPWpGaD
Tofisopam—PDE4A—GPCR downstream signaling—RASGRP1—Crohn's disease	0.000459	0.00288	CbGpPWpGaD
Tofisopam—CYP3A4—Metapathway biotransformation—GPX4—Crohn's disease	0.000448	0.00281	CbGpPWpGaD
Tofisopam—PDE3A—GPCR downstream signaling—RASGRP1—Crohn's disease	0.000447	0.0028	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—UBE2D1—Crohn's disease	0.000445	0.00278	CbGpPWpGaD
Tofisopam—PDE2A—GPCR downstream signaling—CXCL8—Crohn's disease	0.000444	0.00278	CbGpPWpGaD
Tofisopam—PDE2A—Signaling by GPCR—JAK2—Crohn's disease	0.000442	0.00277	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—IL3—Crohn's disease	0.000431	0.0027	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—RIPK2—Crohn's disease	0.000431	0.0027	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—IL3—Crohn's disease	0.00042	0.00263	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—SMAD3—Crohn's disease	0.00042	0.00263	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—IL3—Crohn's disease	0.000419	0.00263	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—RASGRP1—Crohn's disease	0.000417	0.00261	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—RASGRP1—Crohn's disease	0.000407	0.00255	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—RASGRP1—Crohn's disease	0.000406	0.00254	CbGpPWpGaD
Tofisopam—PDE2A—Signaling by GPCR—CXCL8—Crohn's disease	0.000404	0.00253	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—IL2RA—Crohn's disease	0.000389	0.00243	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—ALB—Crohn's disease	0.00037	0.00232	CbGpPWpGaD
Tofisopam—PDE10A—GPCR downstream signaling—JAK2—Crohn's disease	0.000369	0.00231	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—SOCS1—Crohn's disease	0.000368	0.00231	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—TYK2—Crohn's disease	0.000351	0.0022	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—JAK2—Crohn's disease	0.000344	0.00215	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—CCR6—Crohn's disease	0.00034	0.00213	CbGpPWpGaD
Tofisopam—PDE10A—GPCR downstream signaling—CXCL8—Crohn's disease	0.000337	0.00211	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—JAK2—Crohn's disease	0.000335	0.0021	CbGpPWpGaD
Tofisopam—PDE4A—GPCR downstream signaling—IL2RA—Crohn's disease	0.000333	0.00208	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—CCR6—Crohn's disease	0.00033	0.00207	CbGpPWpGaD
Tofisopam—PDE3A—GPCR downstream signaling—IL2RA—Crohn's disease	0.000324	0.00203	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—SMAD3—Crohn's disease	0.000318	0.00199	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—RBX1—Crohn's disease	0.000307	0.00192	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—CXCL8—Crohn's disease	0.000306	0.00192	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—IL2RA—Crohn's disease	0.000302	0.00189	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—PTGER4—Crohn's disease	0.000299	0.00187	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—RBX1—Crohn's disease	0.000299	0.00187	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—IL2RA—Crohn's disease	0.000295	0.00184	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—IL2RA—Crohn's disease	0.000294	0.00184	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—PTGER4—Crohn's disease	0.000291	0.00182	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—TYK2—Crohn's disease	0.000274	0.00171	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—UBE2D1—Crohn's disease	0.000269	0.00169	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—UBE2D1—Crohn's disease	0.000262	0.00164	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—RIPK2—Crohn's disease	0.000261	0.00164	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—JAK2—Crohn's disease	0.000261	0.00164	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—IL3—Crohn's disease	0.000255	0.00159	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—RIPK2—Crohn's disease	0.000254	0.00159	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—IL3—Crohn's disease	0.000248	0.00155	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—RASGRP1—Crohn's disease	0.000246	0.00154	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—RASGRP1—Crohn's disease	0.00024	0.0015	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—CXCL8—Crohn's disease	0.000238	0.00149	CbGpPWpGaD
Tofisopam—PDE2A—Signaling by GPCR—IL6—Crohn's disease	0.000227	0.00142	CbGpPWpGaD
Tofisopam—PDE4A—GPCR downstream signaling—JAK2—Crohn's disease	0.000224	0.0014	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—SOCS1—Crohn's disease	0.000223	0.0014	CbGpPWpGaD
Tofisopam—PDE3A—GPCR downstream signaling—JAK2—Crohn's disease	0.000217	0.00136	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—SOCS1—Crohn's disease	0.000217	0.00136	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—TYK2—Crohn's disease	0.000213	0.00133	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—TYK2—Crohn's disease	0.000208	0.0013	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—TYK2—Crohn's disease	0.000207	0.0013	CbGpPWpGaD
Tofisopam—PDE4A—GPCR downstream signaling—CXCL8—Crohn's disease	0.000204	0.00128	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—JAK2—Crohn's disease	0.000203	0.00127	CbGpPWpGaD
Tofisopam—PDE3A—GPCR downstream signaling—CXCL8—Crohn's disease	0.000199	0.00124	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—JAK2—Crohn's disease	0.000198	0.00124	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—JAK2—Crohn's disease	0.000198	0.00124	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—SMAD3—Crohn's disease	0.000193	0.00121	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—STAT3—Crohn's disease	0.000192	0.0012	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—SMAD3—Crohn's disease	0.000187	0.00117	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—CXCL8—Crohn's disease	0.000185	0.00116	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—CXCL8—Crohn's disease	0.000181	0.00113	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—CXCL8—Crohn's disease	0.00018	0.00113	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—IL2RA—Crohn's disease	0.000178	0.00112	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—IL2RA—Crohn's disease	0.000174	0.00109	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—IL6—Crohn's disease	0.000172	0.00108	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—STAT3—Crohn's disease	0.000145	0.00091	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—IL6—Crohn's disease	0.000134	0.000839	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—TYK2—Crohn's disease	0.000126	0.000787	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—PLA2G4F—Crohn's disease	0.000125	0.000785	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—TYK2—Crohn's disease	0.000122	0.000766	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—JAK2—Crohn's disease	0.00012	0.000751	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—JAK2—Crohn's disease	0.000117	0.000731	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—CXCL8—Crohn's disease	0.000109	0.000685	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—MTMR3—Crohn's disease	0.000107	0.000667	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—CXCL8—Crohn's disease	0.000106	0.000667	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—IL6—Crohn's disease	0.000104	0.000652	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—IL6—Crohn's disease	0.000101	0.000635	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—IL6—Crohn's disease	0.000101	0.000634	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—STAT3—Crohn's disease	8.8e-05	0.000551	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—STAT3—Crohn's disease	8.56e-05	0.000536	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—FADS1—Crohn's disease	8.3e-05	0.00052	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—GPX4—Crohn's disease	7.77e-05	0.000487	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—GCKR—Crohn's disease	7.51e-05	0.00047	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—IL6—Crohn's disease	6.15e-05	0.000385	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—IL6—Crohn's disease	5.98e-05	0.000375	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—ALB—Crohn's disease	2.39e-05	0.00015	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—PTGS2—Crohn's disease	2.09e-05	0.000131	CbGpPWpGaD
